Review
Published on 03 Apr 2025
Fibroblast heterogeneity and its role in generating protective immunity in the secondary lymphoid organs
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1519789
- 238 views
Type at least 3 characters
43,061 articles
Original Research
Published on 03 Apr 2025
mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1505871
- 412 views
Review
Published on 03 Apr 2025
Influence of cell bioenergetics on host-pathogen interaction in the lung
in Microbial Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1549293
- 160 views
Perspective
Published on 03 Apr 2025
Monitoring immunological COVID-19 vaccine clinical testing across the CEPI Centralized Laboratory Network
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1569251
- 182 views
Case Report
Published on 03 Apr 2025
Case Report: Decentralized trial of tolerability-adapted exercise therapy after severe Covid-19
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1529385
- 343 views
Review
Accepted on 02 Apr 2025
Regulation of the Tuft Cell-ILC2 Circuit in Intestinal Mucosal
in Mucosal Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1568062
Review
Accepted on 02 Apr 2025
Circular RNAs in inflammatory bowel disease: A review of mechanisms, biomarkers and therapeutic potential
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1540768
Mini Review
Accepted on 02 Apr 2025
Dendritic Cells in Multiple Myeloma: From Immune Evasion to Therapeutic Potential
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1575509
Original Research
Accepted on 02 Apr 2025
The CD38+ HLA-DR+ T Cells with Activation and Exhaustion Characteristics as Predictors of Severity and Mortality in COVID-19 patients
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1577803
Review
Accepted on 02 Apr 2025
Role and Mechanisms of Exercise Therapy in Enhancing Drug Treatment for Glioma: A Review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1576283
Review
Accepted on 02 Apr 2025
Long non-coding RNAs as Key Modulators of the Immune Microenvironment in Hepatocellular Carcinoma: Implications for Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1523190
Review
Accepted on 02 Apr 2025
Tissue-Resident Immune Cells in Cervical Cancer: Emerging Roles and Therapeutic Implications
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1541950
Original Research
Accepted on 02 Apr 2025
Ubiquitination and ALL: Identifying FBXO8 as a Prognostic Biomarker and Therapeutic Target
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1554231
Case Report
Accepted on 02 Apr 2025
SMARCA4-deficient NSCLC treated with first-line Tislelizumab and Fruquintinib achieved remarkable tumor regression: Case Report and Literature review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1521828
Methods
Accepted on 02 Apr 2025
SAPrIm 2.0: A semi-automated protocol for midthroughput soluble HLA immunopeptidomics
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1546629
Mini Review
Accepted on 02 Apr 2025
Enhancing the Physiological Characteristics of Chimeric Antigen Receptor Natural Killer Cells by Synthetic Biology
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1592121